Skip to main content

Table 1 Baseline and postoperative characteristics of patients, according to vital status (after 1-year follow-up)

From: Post-operative stress hyperglycemia is a predictor of mortality in liver transplantation

Variable

Survivors at 1 year (n = 542)

Non-survivors at 1 year (n = 90)

P value

Age, years

51 ± 11

55 ± 12

0.001

Males, n (%)

416 (77)

58 (64)

0.012

Body mass index, kg/m2

26.9 ± 3.9

26.5 ± 3.4

0.288

Diabetes, n (%)

111 (20)

14 (16)

0.513

Aetiology, n (%)

 Alcohol

338 (62)

48 (53)

0.220

 HCV

109 (20)

21 (23)

0.484

 Malignant

143 (26)

31 (34)

0.113

 Fulminant

24 (4)

9 (10)

0.021

MELD

13 ± 6

17 ± 8

< 0.001

Glucose, mg/dL

130 ± 74

128 ± 72

0.709

Creatinine, mg/dL

0.9 ± 0.5

0.9 ± 0.4

0.221

CIT, hours

7.5 ± 2.2

7.7 ± 2.2

0.330

RBC transfusion, units

5 [2, 10]

10 [4, 17]

< 0.001

PT, units

0 [0, 1]

0 [0, 2]

0.170

PN, days

4 [3, 6]

6 [4, 10]

< 0.001

CVVHDF, n (%)

60 (11)

17 (18)

0.044

Metilprednisolona

537 (99)

89 (99)

0.759

Tacrolimus

444 (83)

89 (99)

0.058

Ciclosporina

161 (30)

20 (22)

0.156

  1. Data are expressed as mean ± SD or medians [25th percentile, 75th percentile]
  2. Pre-operative glucose and creatinine levels are shown
  3. BMI body mass index, CIT cold ischaemia time, CVVHDF continuous veno-venous haemodiafiltration, HCV hepatitis C virus, MELD Model for End-stage Liver Disease score, PN parenteral nutrition, PT platelet requirements, RBC red blood cell requirements